Aethlon Medical Book Value Per Share Growth & History (AEMD)
Aethlon Medical's book value per share was $15.56 for fiscal 2026.
View full Aethlon Medical company overviewAethlon Medical annual book value per share history
| Fiscal year | Period ended | Book value per share | Change | Growth |
|---|---|---|---|---|
| 2026 | 2026-03-31 | $15.56 | -$111.85 | −87.79% |
| 2025 | 2025-03-31 | $127.40 | $39.70 | +45.26% |
| 2024 | 2024-03-31 | $87.71 | -$174.36 | −66.53% |
| 2023 | 2023-03-31 | $262.07 | -$178.72 | −40.54% |
| 2022 | 2022-03-31 | $440.79 | $196.14 | +80.17% |
| 2021 | 2021-03-31 | $244.65 | -$157.18 | −39.12% |
| 2020 | 2020-03-31 | $401.82 | -$363.81 | −47.52% |
| 2019 | 2019-03-31 | $765.64 | -$1,309.07 | −63.10% |
| 2018 | 2018-03-31 | $2,074.70 | $1,613.38 | +349.73% |
| 2017 | 2017-03-31 | $461.32 | -$760.91 | −62.26% |
| 2016 | 2016-03-31 | $1,222.23 | $667.52 | +120.34% |
| 2015 | 2015-03-31 | $554.71 | $20,488.26 | — |
| 2014 | 2014-03-31 | -$19,933.55 | -$4,137.69 | — |
| 2013 | 2013-03-31 | -$15,795.86 | $7,934.43 | — |
| 2012 | 2012-03-31 | -$23,730.29 | -$588.81 | — |
| 2011 | 2011-03-31 | -$23,141.48 | — | — |
Aethlon Medical quarterly book value per share
| Fiscal quarter | Period ended | Book value per share | Change | YoY change |
|---|---|---|---|---|
| Q1 2027 | 2026-06-30 | $10.89 | $4.30 | +65.34% |
| Q4 2026 | 2026-03-31 | $15.56 | -$111.85 | −87.79% |
| Q3 2026 | 2025-12-31 | $34.49 | $22.09 | +178.25% |
| Q2 2026 | 2025-09-30 | $37.74 | $20.49 | +118.84% |
| Q1 2026 | 2025-06-30 | $6.59 | -$18.42 | −73.66% |
| Q4 2025 | 2025-03-31 | $127.40 | $39.70 | +45.26% |
| Q3 2025 | 2024-12-31 | $12.40 | -$104.86 | −89.43% |
| Q2 2025 | 2024-09-30 | $17.24 | -$148.33 | −89.59% |
| Q1 2025 | 2024-06-30 | $25.01 | -$186.13 | −88.16% |
| Q4 2024 | 2024-03-31 | $87.71 | -$174.36 | −66.53% |
| Q3 2024 | 2023-12-31 | $117.25 | -$183.66 | −61.03% |
| Q2 2024 | 2023-09-30 | $165.58 | -$180.76 | −52.19% |
| Q1 2024 | 2023-06-30 | $211.13 | -$162.02 | −43.42% |
| Q4 2023 | 2023-03-31 | $262.07 | -$178.72 | −40.54% |
| Q3 2023 | 2022-12-31 | $300.91 | -$236.48 | −44.01% |
| Q2 2023 | 2022-09-30 | $346.34 | -$252.17 | −42.13% |
| Q1 2023 | 2022-06-30 | $373.15 | -$273.49 | −42.29% |
| Q4 2022 | 2022-03-31 | $440.79 | $196.14 | +80.17% |
| Q3 2022 | 2021-12-31 | $537.39 | $155.67 | +40.78% |
| Q2 2022 | 2021-09-30 | $598.51 | $145.17 | +32.02% |
| Q1 2022 | 2021-06-30 | $646.64 | $138.95 | +27.37% |
| Q4 2021 | 2021-03-31 | $244.65 | -$157.18 | −39.12% |
| Q3 2021 | 2020-12-31 | $381.72 | $52.49 | +15.94% |
| Q2 2021 | 2020-09-30 | $453.35 | $408.73 | +916.14% |
| Q1 2021 | 2020-06-30 | $507.69 | $148.05 | +41.16% |
| Q4 2020 | 2020-03-31 | $401.82 | -$363.81 | −47.52% |
| Q3 2020 | 2019-12-31 | $329.23 | -$734.04 | −69.04% |
| Q2 2020 | 2019-09-30 | $44.61 | -$1,344.05 | −96.79% |
| Q1 2020 | 2019-06-30 | $359.64 | -$1,403.15 | −79.60% |
| Q4 2019 | 2019-03-31 | $765.64 | -$1,309.07 | −63.10% |
| Q3 2019 | 2018-12-31 | $1,063.27 | -$770.75 | −42.03% |
| Q2 2019 | 2018-09-30 | $1,388.67 | $1,320.76 | +1944.92% |
| Q1 2019 | 2018-06-30 | $1,762.80 | $2,348.17 | — |
| Q4 2018 | 2018-03-31 | $2,074.70 | $1,613.38 | +349.73% |
| Q3 2018 | 2017-12-31 | $1,834.02 | $1,776.57 | +3092.58% |
| Q2 2018 | 2017-09-30 | $67.91 | $120.53 | — |
| Q1 2018 | 2017-06-30 | -$585.37 | -$926.47 | — |
| Q4 2017 | 2017-03-31 | $461.32 | -$760.91 | −62.26% |
| Q3 2017 | 2016-12-31 | $57.45 | -$2,106.86 | −97.35% |
| Q2 2017 | 2016-09-30 | -$52.62 | -$3,126.20 | — |
| Q1 2017 | 2016-06-30 | $341.10 | -$3,660.12 | −91.48% |
| Q4 2016 | 2016-03-31 | $1,222.23 | $667.52 | +120.34% |
| Q3 2016 | 2015-12-31 | $2,164.30 | $1,050.29 | +94.28% |
| Q2 2016 | 2015-09-30 | $3,073.58 | $6,977.08 | — |
| Q1 2016 | 2015-06-30 | $4,001.22 | $8,370.80 | — |
| Q4 2015 | 2015-03-31 | $554.71 | $20,488.26 | — |
| Q3 2015 | 2014-12-31 | $1,114.01 | $16,615.19 | — |
| Q2 2015 | 2014-09-30 | -$3,903.50 | $14,162.16 | — |
| Q1 2015 | 2014-06-30 | -$4,369.58 | $10,125.31 | — |
| Q4 2014 | 2014-03-31 | -$19,933.55 | -$4,137.69 | — |
| Q3 2014 | 2013-12-31 | -$15,501.18 | -$2,072.21 | — |
| Q2 2014 | 2013-09-30 | -$18,065.66 | -$1,535.50 | — |
| Q1 2014 | 2013-06-30 | -$14,494.89 | $3,486.87 | — |
| Q4 2013 | 2013-03-31 | -$15,795.86 | $7,934.43 | — |
| Q3 2013 | 2012-12-31 | -$13,428.97 | $3,383.28 | — |
| Q2 2013 | 2012-09-30 | -$16,530.16 | $2,299.28 | — |
| Q1 2013 | 2012-06-30 | -$17,981.76 | $2,706.40 | — |
| Q4 2012 | 2012-03-31 | -$23,730.29 | -$588.81 | — |
| Q3 2012 | 2011-12-31 | -$16,812.25 | — | — |
| Q2 2012 | 2011-09-30 | -$18,829.44 | — | — |
| Q1 2012 | 2011-06-30 | -$20,688.16 | — | — |
| Q4 2011 | 2011-03-31 | -$23,141.48 | — | — |
Aethlon Medical book value per share trends
Over the last five fiscal years, Aethlon Medical's book value per share decreased from $244.65 to $15.56, a change of -$229.09. The latest reported quarter, Q1 2027, shows $10.89.
What book value per share means
Book value per share estimates the common shareholders’ accounting equity represented by each share. It can help compare a company’s balance-sheet value over time, although market value can differ substantially from book value.
How book value per share is calculated
TickerStat calculates book value per share as SEC-reported common shareholders’ equity divided by reported period-end common shares. Preferred equity is subtracted when separately reported, and basic weighted-average shares are used only when period-end shares are unavailable. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Aethlon Medical source filings ↗